ADRIENNE GAROFALO: Open Payments
NPI 1962831941 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 54 payments from 8 companies in 2025. Trend: 2023 $609 · 2024 $2,009 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 35 | $643 |
| TG Therapeutics, Inc. | 11 | $441 |
| Biogen, Inc. | 2 | $139 |
| ABBVIE INC. | 2 | $44 |
| Celgene Corporation | 1 | $33 |
| PFIZER INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Genentech, Inc. | 1 | $17 |
Products named: BRIUMVI, TYSABRI, QULIPTA, ZEPOSIA, NURTEC ODT, KESIMPTA, Ocrevus Zunovo.
Industry payments across NY — which companies pay providers there.
